Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201108083 Principal Investigator: Schroeder, Mark
Title: A Phase II Trial Evaluating the Safety and Efficacy of Plerixafor and Sargramostim (GM-CSF) for the Mobilization of Peripheral Blood Stem Cells (PBSCs) from Normal HLA-Matched Allogeneic Sibling Donors
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The main purpose of this study is to gather information about the combination of the drugs plerixafor with sargramostim in donors of blood-forming cells (stem cells). This study will look at how safe this combination is and how patients tolerate the treatment.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)